Utility of ElastPQ point-shear wave elastography in the work-up of patients with primary sclerosing cholangitis

Utility of ElastPQ point-shear wave elastography in the work-up of patients with primary sclerosing cholangitis

Background & Aims: Liver stiffness measurement (LSM) and spleen stiffness measurement (SSM) have been shown to be useful tools for assessing the risk of fibrosis and portal hypertension, respectively. However, data on the accuracy of LSM and SSM measured by point-shear wave elastography (pSW...

Full description

Bibliographic Details
Main Authors:	Davide Roccarina, Francesca Saffioti, Matteo Rosselli, Aileen Marshall, Massimo Pinzani, Douglas Thorburn
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	JHEP Reports
Subjects:	Autoimmune cholangiopathies chronic cholestatic liver diseases compensated advanced chronic liver disease risk stratification portal hypertension upper gastrointestinal varices
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589555923002045

Similar Items

Transplantation for Primary Sclerosing Cholangitis: Outcomes and Recurrence
by: Fuat H. Saner, et al.
Published: (2023-05-01)

Understanding illness experiences of patients with primary sclerosing cholangitis: a qualitative analysis within the SOMA.LIV study
by: Caroline Loesken, et al.
Published: (2023-01-01)

Reversine attenuates cholestatic ductular reaction in rats
by: Di Huang, et al.
Published: (2023-05-01)

Decompensated chronic liver disease: A review of current concepts and management guidelines
by: Ruchir Bhavsar, et al.
Published: (2022-01-01)

The Role of Shear-Wave Elastography of the Spleen in Ruling out the Presence of High-Risk Varices in Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Vasile-Andrei Olteanu, et al.
Published: (2023-05-01)

Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation: Single-Center Data
by: Elisa Catanzaro, et al.
Published: (2024-02-01)

Suppression of bile acid synthesis as a tipping point in the disease course of primary sclerosing cholangitis
by: Peder Rustøen Braadland, et al.
Published: (2022-11-01)

Primary Sclerosing Cholangitis: Diagnostic Criteria
by: Nora Cazzagon, et al.
Published: (2024-01-01)

Noninvasive Assessment of Liver Fibrosis with ElastPQ in Patients with Chronic Viral Hepatitis: Comparison Using Histopathological Findings
by: Dongmin Choo, et al.
Published: (2022-03-01)

Spleen Stiffness on Magnetic Resonance Elastography for the Detection of Portal Hypertension: A Systematic Review and Meta-Analysis
by: Ma Yiyi, et al.
Published: (2022-09-01)

Endothelin Receptor-A Inhibition Decreases Ductular Reaction, Liver Fibrosis, and Angiogenesis in a Model of CholangitisSummary
by: Travis Owen, et al.
Published: (2023-01-01)

The Role of hsa-miR-125b-5p Interaction with S1P/Ceramide Axis in the Potential Development of Inflammation-Associated Colon Cancer in Primary Sclerosing Cholangitis
by: Joanna Abramczyk, et al.
Published: (2023-05-01)

Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics
by: Ji-Won Park, et al.
Published: (2022-05-01)

Risk stratification based on acute-on-chronic liver failure in cirrhotic patients hospitalized for acute variceal bleeding
by: Zongyi Zhu, et al.
Published: (2023-05-01)

High Rate of Gastrointestinal Bleeding in Patients with Secondary Sclerosing Cholangitis in Critically Ill Patients (SC-CIP)
by: Andreas Blesl, et al.
Published: (2021-04-01)

High correlation of hepatic shear wave velocity with esophageal varices complication rate in patients with chronic liver diseases
by: Shouichi Namikawa, et al.
Published: (2023-05-01)

Recent discoveries in microbiota dysbiosis, cholangiocytic factors, and models for studying the pathogenesis of primary sclerosing cholangitis
by: Huang Yu, et al.
Published: (2022-05-01)

Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis
by: Diletta Overi, et al.
Published: (2022-11-01)

Pathophysiology and management of liver cirrhosis: from portal hypertension to acute-on-chronic liver failure
by: Rakesh Kumar Jagdish, et al.
Published: (2023-06-01)

Management of varices but not anticoagulation is associated with improved outcome in patients with HCC and macrovascular tumour invasion
by: Lorenz Balcar, et al.
Published: (2024-01-01)

Combi-Elasto Evaluation of the Degree of Liver Fibrosis in Children with Cholestatic Liver Disease
by: Rina Li, et al.
Published: (2023-10-01)

Tamoxifen Ameliorates Cholestatic Liver Fibrosis in Mice: Upregulation of TGFβ and IL6 Is a Potential Protective Mechanism
by: Dino Šisl, et al.
Published: (2022-05-01)

COMPARISION OF THE EFFICACY OF CARVEDILPL AND PROPRANOLOL IN THE SECONDARY PREVENTION OF ESOPHAGEAL VARICEAL BLEEDING
by: Irshad Ahmed, et al.
Published: (2016-03-01)

Portal vein congestion index in patients with and without chronic liver disease
by: Ogholoh Oghenetejiri Denise, et al.
Published: (2023-06-01)

Ultrasonographic Determination of Portal Vein Diameter Among Adults with and without Chronic Liver Disease at Selected Referral Hospitals in Southern Ethiopia
by: Ayele T, et al.
Published: (2022-01-01)

Application of Ultrasound Elastography in Assessing Portal Hypertension
by: Man Zhang, et al.
Published: (2022-09-01)

The Diagnostic Accuracy of LOGIQ S8 and E9 Shear Wave Elastography for Staging Hepatic Fibrosis, in Comparison with Transient Elastography
by: Jeong-Ju Yoo, et al.
Published: (2021-10-01)

Our experience with liver and spleen elastography in the prediction of oesophageal varices
by: Shivali Arya, et al.
Published: (2024-01-01)

Creatine Supplementation to Improve Sarcopenia in Chronic Liver Disease: Facts and Perspectives
by: Riccardo Casciola, et al.
Published: (2023-02-01)

Changes in intestinal fungal diversity and compositions in patients with cholestatic liver disease
by: LI Zhen, et al.
Published: (2022-06-01)

Systemic exposure to propranolol in patients with chronic liver disease and its correlation with portal blood flow
by: Tae-Eun Kim, et al.
Published: (2022-09-01)

Correlation between portal vein diameter and craniocaudal length of the spleen
by: Shah Zaman, et al.
Published: (2019-12-01)

Transient elastography and von Willebrand factor as predictors of portal hypertension and decompensation in children
by: Akshat Goel, et al.
Published: (2023-12-01)

Targeting Gut–Liver Axis for Treatment of Liver Fibrosis and Portal Hypertension
by: Eric Kalo, et al.
Published: (2021-09-01)

Endoscopic ultrasound-guided coiling and glue is safe and superior to endoscopic glue injection in gastric varices with severe liver disease: a retrospective case control study
by: Kapil D. Jamwal, et al.
Published: (2023-01-01)

Clinical Profile and Upper Gastrointestinal Endoscopy Findings of Patients Presenting with Liver Cirrhosis with Portal Hypertension
by: Shatdal Chaudhary, et al.
Published: (2020-02-01)

SURGICAL METHODS OF BLEEDING PREVENTION FROM ESOPHAGEAL VARICES IN TREATMENT FOR PATIENTS WITH LIVER CIRRHOSIS
by: M. F. Zarivchatskiy, et al.
Published: (2017-04-01)

Peroxisome Proliferator-Activated Receptors Regulate Hepatic Immunity and Assist in the Treatment of Primary Biliary Cholangitis
by: Chang Wang, et al.
Published: (2022-07-01)

Network Proximity-Based Drug Repurposing Strategy for Early and Late Stages of Primary Biliary Cholangitis
by: Endrit Shahini, et al.
Published: (2022-07-01)

Primary sclerosing cholangitis with partial steroid responsiveness: a case report
by: Satoshi Yamamoto, et al.
Published: (2023-05-01)